DELAYED PHASE SLEEP SYNDROME, INSOMNIA IN THE ELDERLY, SLEEP DISTURBANCES IN
CHILDREN WITH NEURO-PSYCHIATRIC DISORDERS, AND SLEEP ENHANCEMENT IN HEALTHY
PEOPLE
SUGGESTED BUT UNPROVEN USES: NEUROPROTECTION
SUGGESTED BUT UNPROVEN USES: INSOMNIA
SUGGESTED BUT UNPROVEN USES: SCHIZOPHRENIA
SUGGESTED BUT UNPROVEN USES: BENZODIAZEPINE WITHDRAWAL AND HIGH-ALTITUDE
ADJUSTMENT
SUGGESTED BUT UNPROVEN USES: SLEEP PATTERNS
SUGGESTED BUT UNPROVEN USES: CIRCADIAN SLEEP DISORDERS [CYCLICAL MELATONIN
DEFICIENCY]
SUGGESTED BUT UNPROVEN USES: MAJOR DEPRESSION, SEASONAL AFFECTIVE DISORDER,
AND DRUG WITHDRAWAL
SUGGESTED BUT UNPROVEN USES: INSOMNIA IN DEMENTIA, INSOMNIA IN PEOPLE WITH
AUTISM, RAPID EYE MOVEMENT BEHAVIOR DISORDER, “SUNDOWNING”/SLEEP PATTERN
ADJUSTMENT
SUGGESTED BUT UNPROVEN USES: ADJUNCTIVE USE
THE NATURAL STANDARD DISSENTS
DRUG INTERACTIONS
SIDE EFFECTS
DOSAGE
Melatonin (N-acetyl- 5 - methoxytryptamine) is a neurohormone that is primarily produced
by the pineal gland, located behind the third ventricle in the brain. In the synthesis of
